Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
It has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in 1817. The disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although the pathogenesis of PD is still unkno...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnagi.2018.00109/full |
id |
doaj-01e75ab6601a40bdbd19aa49f17f26ec |
---|---|
record_format |
Article |
spelling |
doaj-01e75ab6601a40bdbd19aa49f17f26ec2020-11-25T00:11:24ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652018-04-011010.3389/fnagi.2018.00109351713Cellular and Molecular Basis of Neurodegeneration in Parkinson DiseaseXian-Si ZengWen-Shuo GengJin-Jing JiaLei ChenPeng-Peng ZhangIt has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in 1817. The disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although the pathogenesis of PD is still unknown, the research findings from scientists are conducive to understand the pathological mechanisms. It is well accepted that both genetic and environmental factors contribute to the onset of PD. In this review, we summarize the mutations of main seven genes (α-synuclein, LRRK2, PINK1, Parkin, DJ-1, VPS35 and GBA1) linked to PD, discuss the potential mechanisms for the loss of dopaminergic neurons (dopamine metabolism, mitochondrial dysfunction, endoplasmic reticulum stress, impaired autophagy, and deregulation of immunity) in PD, and expect the development direction for treatment of PD.http://journal.frontiersin.org/article/10.3389/fnagi.2018.00109/fullParkinson diseaseneurodegenerationgene mutationneuronal deathmechanism |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xian-Si Zeng Wen-Shuo Geng Jin-Jing Jia Lei Chen Peng-Peng Zhang |
spellingShingle |
Xian-Si Zeng Wen-Shuo Geng Jin-Jing Jia Lei Chen Peng-Peng Zhang Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease Frontiers in Aging Neuroscience Parkinson disease neurodegeneration gene mutation neuronal death mechanism |
author_facet |
Xian-Si Zeng Wen-Shuo Geng Jin-Jing Jia Lei Chen Peng-Peng Zhang |
author_sort |
Xian-Si Zeng |
title |
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease |
title_short |
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease |
title_full |
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease |
title_fullStr |
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease |
title_full_unstemmed |
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease |
title_sort |
cellular and molecular basis of neurodegeneration in parkinson disease |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Aging Neuroscience |
issn |
1663-4365 |
publishDate |
2018-04-01 |
description |
It has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in 1817. The disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although the pathogenesis of PD is still unknown, the research findings from scientists are conducive to understand the pathological mechanisms. It is well accepted that both genetic and environmental factors contribute to the onset of PD. In this review, we summarize the mutations of main seven genes (α-synuclein, LRRK2, PINK1, Parkin, DJ-1, VPS35 and GBA1) linked to PD, discuss the potential mechanisms for the loss of dopaminergic neurons (dopamine metabolism, mitochondrial dysfunction, endoplasmic reticulum stress, impaired autophagy, and deregulation of immunity) in PD, and expect the development direction for treatment of PD. |
topic |
Parkinson disease neurodegeneration gene mutation neuronal death mechanism |
url |
http://journal.frontiersin.org/article/10.3389/fnagi.2018.00109/full |
work_keys_str_mv |
AT xiansizeng cellularandmolecularbasisofneurodegenerationinparkinsondisease AT wenshuogeng cellularandmolecularbasisofneurodegenerationinparkinsondisease AT jinjingjia cellularandmolecularbasisofneurodegenerationinparkinsondisease AT leichen cellularandmolecularbasisofneurodegenerationinparkinsondisease AT pengpengzhang cellularandmolecularbasisofneurodegenerationinparkinsondisease |
_version_ |
1725404190238310400 |